Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

InMed Pharmaceuticals (INM) Assets Average (2021 - 2025)

InMed Pharmaceuticals (INM) has 5 years of Assets Average data on record, last reported at $12.3 million in Q4 2025.

  • For Q4 2025, Assets Average rose 29.45% year-over-year to $12.3 million; the TTM value through Dec 2025 reached $12.3 million, up 29.45%, while the annual FY2025 figure was $13.7 million, 5.68% up from the prior year.
  • Assets Average reached $12.3 million in Q4 2025 per INM's latest filing, down from $14.5 million in the prior quarter.
  • Across five years, Assets Average topped out at $18.4 million in Q4 2021 and bottomed at $8.9 million in Q1 2025.
  • Average Assets Average over 5 years is $13.6 million, with a median of $13.7 million recorded in 2022.
  • The widest YoY moves for Assets Average: up 29.85% in 2025, down 37.86% in 2025.
  • A 5-year view of Assets Average shows it stood at $18.4 million in 2021, then decreased by 14.18% to $15.8 million in 2022, then fell by 16.92% to $13.1 million in 2023, then dropped by 27.53% to $9.5 million in 2024, then grew by 29.45% to $12.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Assets Average were $12.3 million in Q4 2025, $14.5 million in Q3 2025, and $12.4 million in Q2 2025.